Thiazolyl MGLUR5 antagonists and methods for their use

The identification of a unique series of 1,3 thiazoles which possesses special advantages in terms of drug-like properties due to their possessing advantageous properties in terms of potency and/or pharmacokinetic and/or selectivity and/or in vivo receptor occupancy properties. Specifically, the sel...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KING, CHRIS, HUANG, DEHUA, ROPPE, JEFFREY, R, POON, STEVE, F, PAYNE, JOSEPH, EASTMAN, BRIAN, W, ARRUDA, JEANNIE, M, SMITH, NICHOLAS, D, SEIDERS, THOMAS, J, COSFORD, NICHOLAS, D, VERNIER, JEAN-MICHEL, ZHAO, XIUMIN, WANG, BOWEI
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator KING, CHRIS
HUANG, DEHUA
ROPPE, JEFFREY, R
POON, STEVE, F
PAYNE, JOSEPH
EASTMAN, BRIAN, W
ARRUDA, JEANNIE, M
SMITH, NICHOLAS, D
SEIDERS, THOMAS, J
COSFORD, NICHOLAS, D
VERNIER, JEAN-MICHEL
ZHAO, XIUMIN
WANG, BOWEI
description The identification of a unique series of 1,3 thiazoles which possesses special advantages in terms of drug-like properties due to their possessing advantageous properties in terms of potency and/or pharmacokinetic and/or selectivity and/or in vivo receptor occupancy properties. Specifically, the selection of a 1,3-thiazol-2-yl ring member linked by an ethynylene to the 3 position of a pyridyl ring or the 5 position of a pyrimidinyl ring, wherein the ring is substituted with selected substituents, results in a compound having superior drug-like properties. The invention includes pharmaceutically acceptable salt forms of these heterocyclic compounds, in particular chloride salts and trifluoroacetate salts.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP2380889B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP2380889B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP2380889B13</originalsourceid><addsrcrecordid>eNrjZDALychMrMrPqcxR8HX3CQ0yVUjMK0lMz8_LLC4pBrJTFHJTSzLyU4oV0vKLFEoyUjOLFEqLU3kYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSbxrgJGxhYGFhaWToTERSgAGPSyx</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Thiazolyl MGLUR5 antagonists and methods for their use</title><source>esp@cenet</source><creator>KING, CHRIS ; HUANG, DEHUA ; ROPPE, JEFFREY, R ; POON, STEVE, F ; PAYNE, JOSEPH ; EASTMAN, BRIAN, W ; ARRUDA, JEANNIE, M ; SMITH, NICHOLAS, D ; SEIDERS, THOMAS, J ; COSFORD, NICHOLAS, D ; VERNIER, JEAN-MICHEL ; ZHAO, XIUMIN ; WANG, BOWEI</creator><creatorcontrib>KING, CHRIS ; HUANG, DEHUA ; ROPPE, JEFFREY, R ; POON, STEVE, F ; PAYNE, JOSEPH ; EASTMAN, BRIAN, W ; ARRUDA, JEANNIE, M ; SMITH, NICHOLAS, D ; SEIDERS, THOMAS, J ; COSFORD, NICHOLAS, D ; VERNIER, JEAN-MICHEL ; ZHAO, XIUMIN ; WANG, BOWEI</creatorcontrib><description>The identification of a unique series of 1,3 thiazoles which possesses special advantages in terms of drug-like properties due to their possessing advantageous properties in terms of potency and/or pharmacokinetic and/or selectivity and/or in vivo receptor occupancy properties. Specifically, the selection of a 1,3-thiazol-2-yl ring member linked by an ethynylene to the 3 position of a pyridyl ring or the 5 position of a pyrimidinyl ring, wherein the ring is substituted with selected substituents, results in a compound having superior drug-like properties. The invention includes pharmaceutically acceptable salt forms of these heterocyclic compounds, in particular chloride salts and trifluoroacetate salts.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2013</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20130626&amp;DB=EPODOC&amp;CC=EP&amp;NR=2380889B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20130626&amp;DB=EPODOC&amp;CC=EP&amp;NR=2380889B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KING, CHRIS</creatorcontrib><creatorcontrib>HUANG, DEHUA</creatorcontrib><creatorcontrib>ROPPE, JEFFREY, R</creatorcontrib><creatorcontrib>POON, STEVE, F</creatorcontrib><creatorcontrib>PAYNE, JOSEPH</creatorcontrib><creatorcontrib>EASTMAN, BRIAN, W</creatorcontrib><creatorcontrib>ARRUDA, JEANNIE, M</creatorcontrib><creatorcontrib>SMITH, NICHOLAS, D</creatorcontrib><creatorcontrib>SEIDERS, THOMAS, J</creatorcontrib><creatorcontrib>COSFORD, NICHOLAS, D</creatorcontrib><creatorcontrib>VERNIER, JEAN-MICHEL</creatorcontrib><creatorcontrib>ZHAO, XIUMIN</creatorcontrib><creatorcontrib>WANG, BOWEI</creatorcontrib><title>Thiazolyl MGLUR5 antagonists and methods for their use</title><description>The identification of a unique series of 1,3 thiazoles which possesses special advantages in terms of drug-like properties due to their possessing advantageous properties in terms of potency and/or pharmacokinetic and/or selectivity and/or in vivo receptor occupancy properties. Specifically, the selection of a 1,3-thiazol-2-yl ring member linked by an ethynylene to the 3 position of a pyridyl ring or the 5 position of a pyrimidinyl ring, wherein the ring is substituted with selected substituents, results in a compound having superior drug-like properties. The invention includes pharmaceutically acceptable salt forms of these heterocyclic compounds, in particular chloride salts and trifluoroacetate salts.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2013</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDALychMrMrPqcxR8HX3CQ0yVUjMK0lMz8_LLC4pBrJTFHJTSzLyU4oV0vKLFEoyUjOLFEqLU3kYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSbxrgJGxhYGFhaWToTERSgAGPSyx</recordid><startdate>20130626</startdate><enddate>20130626</enddate><creator>KING, CHRIS</creator><creator>HUANG, DEHUA</creator><creator>ROPPE, JEFFREY, R</creator><creator>POON, STEVE, F</creator><creator>PAYNE, JOSEPH</creator><creator>EASTMAN, BRIAN, W</creator><creator>ARRUDA, JEANNIE, M</creator><creator>SMITH, NICHOLAS, D</creator><creator>SEIDERS, THOMAS, J</creator><creator>COSFORD, NICHOLAS, D</creator><creator>VERNIER, JEAN-MICHEL</creator><creator>ZHAO, XIUMIN</creator><creator>WANG, BOWEI</creator><scope>EVB</scope></search><sort><creationdate>20130626</creationdate><title>Thiazolyl MGLUR5 antagonists and methods for their use</title><author>KING, CHRIS ; HUANG, DEHUA ; ROPPE, JEFFREY, R ; POON, STEVE, F ; PAYNE, JOSEPH ; EASTMAN, BRIAN, W ; ARRUDA, JEANNIE, M ; SMITH, NICHOLAS, D ; SEIDERS, THOMAS, J ; COSFORD, NICHOLAS, D ; VERNIER, JEAN-MICHEL ; ZHAO, XIUMIN ; WANG, BOWEI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP2380889B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2013</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>KING, CHRIS</creatorcontrib><creatorcontrib>HUANG, DEHUA</creatorcontrib><creatorcontrib>ROPPE, JEFFREY, R</creatorcontrib><creatorcontrib>POON, STEVE, F</creatorcontrib><creatorcontrib>PAYNE, JOSEPH</creatorcontrib><creatorcontrib>EASTMAN, BRIAN, W</creatorcontrib><creatorcontrib>ARRUDA, JEANNIE, M</creatorcontrib><creatorcontrib>SMITH, NICHOLAS, D</creatorcontrib><creatorcontrib>SEIDERS, THOMAS, J</creatorcontrib><creatorcontrib>COSFORD, NICHOLAS, D</creatorcontrib><creatorcontrib>VERNIER, JEAN-MICHEL</creatorcontrib><creatorcontrib>ZHAO, XIUMIN</creatorcontrib><creatorcontrib>WANG, BOWEI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KING, CHRIS</au><au>HUANG, DEHUA</au><au>ROPPE, JEFFREY, R</au><au>POON, STEVE, F</au><au>PAYNE, JOSEPH</au><au>EASTMAN, BRIAN, W</au><au>ARRUDA, JEANNIE, M</au><au>SMITH, NICHOLAS, D</au><au>SEIDERS, THOMAS, J</au><au>COSFORD, NICHOLAS, D</au><au>VERNIER, JEAN-MICHEL</au><au>ZHAO, XIUMIN</au><au>WANG, BOWEI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Thiazolyl MGLUR5 antagonists and methods for their use</title><date>2013-06-26</date><risdate>2013</risdate><abstract>The identification of a unique series of 1,3 thiazoles which possesses special advantages in terms of drug-like properties due to their possessing advantageous properties in terms of potency and/or pharmacokinetic and/or selectivity and/or in vivo receptor occupancy properties. Specifically, the selection of a 1,3-thiazol-2-yl ring member linked by an ethynylene to the 3 position of a pyridyl ring or the 5 position of a pyrimidinyl ring, wherein the ring is substituted with selected substituents, results in a compound having superior drug-like properties. The invention includes pharmaceutically acceptable salt forms of these heterocyclic compounds, in particular chloride salts and trifluoroacetate salts.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP2380889B1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Thiazolyl MGLUR5 antagonists and methods for their use
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T05%3A32%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KING,%20CHRIS&rft.date=2013-06-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP2380889B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true